Docetaxel in Treating Patients With Non-Small Cell Lung Cancer

NCT00022022 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: docetaxel
PROCEDURE: quality-of-life assessment

Sponsor

Istituto Nazionale per lo Studio e la Cura dei Tumori